MERIT CRO published an Employee Spotlight article featuring Kareena Ratnesh discussing her role as an Oncology Project Coordinator supporting Operations and Medical Affairs across MERIT's oncology clinical trials.
Published
Signal category
Presence & Recognition
Quote
“In our latest Employee Spotlight, Kareena Ratnesh discusses how as an Oncology Project Coordinator supporting both Operations and Medical Affairs, her role allows her to work across several aspects of MERIT's oncology clinical trials.”
— MERIT CRO team
Company
MERIT CRO
MERIT is a global clinical trial endpoint services provider offering reliable expertise in our therapeutic areas.
- Industry
- Biotechnology Research
- Location
- Madison, US
- Company size
- 171 employees
MERIT is an innovative clinical endpoint expert providing attentive expertise in our therapeutic areas. We partner with CROs, pharma, and biotech companies to deliver reliable endpoint services in global clinical trials. With the acquisition of OSOD, MERIT now offers preclinical research services, enabling a seamless transition from preclinical to clinical phases of drug development. Together our work advances and accelerates the improvement of therapeutic options for patients worldwide. We have a proven track record providing endpoint expertise to 13 of the top 20 global pharmaceutical companies. We prioritize a collaborative, partnership-driven approach for all projects with scalable solutions and personalized attention. If you’re looking for a partner that will bring dedication and expertise to your clinical trial, consider MERIT.
Founded 2012